Tracking the Investment in Cancer Research: 2005 to 2019
Today, the CCRA released its latest report on the investment in cancer research from 2005 to 2019. A grand total of $7.4 billion was invested during this 15-year period. The fluctuating investment in major infrastructure drove peaks and valleys in the overall investment trend. Cancer researchers, however, retained their competitiveness. In recent years, Canada lost ground in terms of its cancer research investment when compared with the U.K. and the U.S. This report has an accompanying Excel file as well as dashboard tools that expand on the findings in the report. To access this report, click here.

Under the leadership of its new Scientific Director, Dr. Angela Kaida, IGH is embarking on a Listening Tour and national planning process to inform its research investments and co-create a new strategic plan to guide its work. How can research excellence regarding the influence of sex and gender on healt...
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical tri...